Lucid Diagnostics Inc. (LUCD) vs MaxCyte, Inc. (MXCT)
- Lucid Diagnostics Inc. LUCD 0.48 −7.69%
- MaxCyte, Inc. MXCT 1.30 0.00%
Lucid Diagnostics Inc. and MaxCyte, Inc. are both Medical Devices companies. MaxCyte, Inc. is the larger, with a market value of $134.2M against $105.7M — 1.3× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −13.2%. MaxCyte, Inc. has the higher net margin (−114.8% vs −1,193.9%) and the higher return on invested capital (−49.2% vs −3,096.5%). Across the 17 metrics below, MaxCyte, Inc. leads on 13 and Lucid Diagnostics Inc. on 4.
Valuation
Profitability
| Metric | LUCD | MXCT | Medical Devices median |
|---|---|---|---|
| Gross margin | (21.69%) | 79.23% | 56.01% |
| Operating margin | (930.84%) | (134.59%) | (15.03%) |
| Net margin | (1,193.87%) | (114.77%) | (20.40%) |
| Free cash flow margin | (866.56%) | (76.14%) | (7.24%) |
| Return on equity | 364.89% | (20.39%) | (15.32%) |
| Return on assets | (167.51%) | (17.62%) | (19.72%) |
| Return on invested capital | (3,096.53%) | (49.23%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack